Expression of MicroRNA 146a, 155, 181 and 223 in febrile seizure

Kürşat Bora Çarman1, Yasemin Karal2, Gülen Gül Mert3

  • 1Division of Pediatric Neurology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir.

Abstract

Insights

MicroRNAs (miRNAs) and inflammatory cytokines are altered in children with febrile seizures (FS). Specifically, miRNA-146a levels were significantly higher in FS patients, suggesting a role in FS pathogenesis.

Area of Science:

  • Pediatric Neurology
  • Molecular Biology
  • Immunology

Background:

  • Febrile seizures (FS) are common in children.
  • The role of microRNAs (miRNAs) and inflammatory cytokines in FS pathogenesis is not fully understood.
  • This study investigates specific miRNAs and cytokines in children with FS.

Purpose of the Study:

  • To compare the expression levels of specific microRNAs (miRNAs) -146a, -155, -181a, and -223 in children with febrile seizures (FS) versus febrile controls.
  • To measure and compare serum levels of proinflammatory cytokines, including tumor necrosis factor alpha (TNF-α), interleukin 1 beta (IL-1β), and interleukin 6 (IL-6), between FS patients and controls.
  • To explore potential correlations between miRNA expressions and clinical characteristics of FS.

Main Methods:

  • Prospective multicenter study conducted in Turkey (June 2018 - July 2019).
  • Inclusion of 60 children: 30 with FS and 30 febrile controls.
  • Real-time PCR for miRNA expression analysis and ELISA for cytokine level quantification.

Main Results:

  • Significantly higher expression of miRNA-146a was observed in children with FS compared to controls.
  • Elevated serum levels of TNF-α, IL-1β, and IL-6 were found in the FS group.
  • Correlations were identified among miRNA expressions in children with FS, but no differences were noted based on FS type or recurrence.

Conclusions:

  • Specific miRNAs, notably miRNA-146a, and proinflammatory cytokines appear to be involved in the pathogenesis of febrile seizures.
  • Altered miRNA expression may represent an adaptive response to inflammation in FS.
  • Findings suggest potential for novel therapeutic strategies targeting miRNA pathways in pediatric FS.